Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

About Us

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for Neglected Diseases.

See DNDi's vision&mission and objectives.

DNDi Brochure 2015
To learn more about DNDi's activities and patients
download our short Presentation Brochure!

English [1.4MB]
Deutsch [0.9MB]
Français [1.2MB]
العربية (Arabic) [0.9MB]
日本語 (Japanese) [3.0MB]

Browse Online »

DNDi is working on the following diseases:
In 2015, DNDi handed over its malaria programme to Medicines for Malaria Venture, and started working on:
Working in partnership with private industry, public institutions, academia and NGOs, DNDi has built the largest ever R&D portfolio for the kinetoplastid diseases and has currently underway five projects in Implementation stage, seven in the clinical, and seven in the pre-clinical.
To date, DNDi has successfully delivered
DNDi initiates and coordinates drug R&D projects in collaboration with
  • the international research community
  • the public sector
  • the pharmaceutical industry
  • and other relevant partners.
DNDi is also working to strengthen existing capacities in disease-endemic countries.
Learn more about DNDi's

and 7 DNDi regional offices in North America, Kenya, India, Brazil, Malaysia, Japan and DRC

See DNDi Worldwide
Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site
is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License